Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$30.6 - $58.1 $434,734 - $825,426
-14,207 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$52.6 - $72.5 $23,564 - $32,480
448 Added 3.26%
14,207 $78,000
Q4 2020

Feb 16, 2021

BUY
$56.0 - $66.7 $770,504 - $917,725
13,759 New
13,759 $88,000

Others Institutions Holding PHGE

About BiomX Inc.


  • Ticker PHGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,982,300
  • Market Cap $15.3M
  • Description
  • BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...
More about PHGE
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.